Literature DB >> 26097593

HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma.

Xinqiong Huang1, Miaomiao Liu1, Hong Sun2, Fengjun Wang2, Xiaoxue Xie3, Xiang Chen4, Juan Su4, Yuxiang He1, Youyi Dai1, Haijun Wu1, Liangfang Shen1.   

Abstract

The mechanism by which overexpression of hexokinase 2 (HK2) indicates locally advanced cervical squamous cell carcinoma (LACSCC) with radio-resistance is still unknown despite being an independent biomarker of poor prognosis. Here, we retrospectively analyzed 132 female patients receiving radiotherapy for cervical squamous cell carcinoma including 85 radiation-sensitive cases and 47 radiation-resistant cases. The expression of HK2 was examined by immunohistochemistry. The percentage of high HK2 expression in the radiation-resistant group differed from the radiation-sensitive group with statistical significance (P < 0.001) even if divided into three subgroups including a lower 5-year progression free survival group (PFS) for comparison (P < 0.001). The Kaplan Meier curve analysis showed that there were differences between the two groups (P < 0.001). Therefore, this study proves a close relationship between HK2 expression and radio-resistance. Multivariate Cox regression analysis implied that HK2 was an independent prognostic indicator of cervical squamous carcinoma (HR (95% CI), 2.940 (1.609, 1.609); P = 0.002).

Entities:  

Keywords:  HK2; Locally advanced cervical squamous cell carcinoma; glycolysis; immunohistochemistry; radiation resistance

Mesh:

Substances:

Year:  2015        PMID: 26097593      PMCID: PMC4466980     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  48 in total

Review 1.  [Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells].

Authors:  Y Shinohara
Journal:  Yakugaku Zasshi       Date:  2000-08       Impact factor: 0.302

Review 2.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 3.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

4.  Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.

Authors:  Xin-Qiong Huang; Xiang Chen; Xiao-Xue Xie; Qin Zhou; Kai Li; Shan Li; Liang-Fang Shen; Juan Su
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 5.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

Review 6.  Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

Authors:  Olivier Feron
Journal:  Radiother Oncol       Date:  2009-07-13       Impact factor: 6.280

7.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

8.  Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

Authors:  Peter L Pedersen; Saroj Mathupala; Annette Rempel; J F Geschwind; Young Hee Ko
Journal:  Biochim Biophys Acta       Date:  2002-09-10

9.  Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.

Authors:  Jian Chen; Sulin Zhang; Yuncheng Li; Zhengang Tang; Weijia Kong
Journal:  Tumour Biol       Date:  2013-12-21

Review 10.  Tumor resistance to apoptosis.

Authors:  Simone Fulda
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

View more
  17 in total

1.  Altered gene expression in conjunctival squamous cell carcinoma.

Authors:  Alka Mahale; Hind Alkatan; Saeed Alwadani; Maha Othman; Maria J Suarez; Antoinette Price; Hailah Al-Hussain; Sabah Jastaneiah; Wayne Yu; Azza Maktabi; Edward P Deepak; Charles G Eberhart; Laura Asnaghi
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer.

Authors:  Bo Wook Kim; Hanbyoul Cho; Kris Ylaya; Haruhisa Kitano; Joon-Yong Chung; Stephen M Hewitt; Jae-Hoon Kim
Journal:  Anticancer Res       Date:  2017-09       Impact factor: 2.480

Review 3.  Drugging cancer metabolism: Expectations vs. reality.

Authors:  David C Montrose; Lorenzo Galluzzi
Journal:  Int Rev Cell Mol Biol       Date:  2019-07-29       Impact factor: 6.813

Review 4.  Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters.

Authors:  Francesco Ciscato; Lavinia Ferrone; Ionica Masgras; Claudio Laquatra; Andrea Rasola
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 5.  Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.

Authors:  Ezequiel Monferrer; Isaac Vieco-Martí; Amparo López-Carrasco; Fernando Fariñas; Sergio Abanades; Luis de la Cruz-Merino; Rosa Noguera; Tomás Álvaro Naranjo
Journal:  Metabolites       Date:  2021-04-23

6.  Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.

Authors:  Yulin Liu; Ke Wu; Liang Shi; Fan Xiang; Kaixiong Tao; Guobin Wang
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

7.  Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines.

Authors:  Karin Hoppe-Seyler; Anja Honegger; Felicitas Bossler; Jasmin Sponagel; Julia Bulkescher; Claudia Lohrey; Felix Hoppe-Seyler
Journal:  Oncotarget       Date:  2017-11-15

Review 8.  Hypoxia in cervical cancer: from biology to imaging.

Authors:  Heidi Lyng; Eirik Malinen
Journal:  Clin Transl Imaging       Date:  2017-07-10

9.  LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.

Authors:  Ji Hee Ha; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Mingda Yan; Jeremy D Ward; Kar-Ming Fung; Katherine Moxley; Anil K Sood; Ciro Isidoro; Priyabrata Mukherjee; Yong Sang Song; Danny N Dhanasekaran
Journal:  Cancer Res       Date:  2018-01-31       Impact factor: 12.701

10.  SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma.

Authors:  Kanako Nakamura; Masayuki Komatsu; Fumiko Chiwaki; Takashi Takeda; Yusuke Kobayashi; Kouji Banno; Daisuke Aoki; Teruhiko Yoshida; Hiroki Sasaki
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.